Reuters logo
BRIEF-Glenmark Pharma gets tentative US FDA nod for Dabigatran Etexilate capsules
April 19, 2017 / 3:19 AM / 5 months ago

BRIEF-Glenmark Pharma gets tentative US FDA nod for Dabigatran Etexilate capsules

April 19 (Reuters) - Glenmark Pharmaceuticals Ltd:

* Receives tentative ANDA approval for Dabigatran Etexilate capsules, 75 mg, 110 mg and 150 mg Source text: bit.ly/2pfaBfp Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below